REFERENCES
- European Pharmacopoeia. 3rd Ed., 1999
- U.S. Pharmacopeial Convention. United States Pharmacopeia 24/National Formulary 19. U.S. Pharmacopeial Convention, Rockville, MD 2000
- Lee J. C., Chen D.-T., Hung H.-N., Chen J. J. Analysis of Drug Dissolution Data. Stat. Med. 1999; 18: 799–814
- Food and Drug Administration. FDA Guidance for Industry: Immediate Release Solid Dosage Forms: Scale-up and Post-Approval Changes (SUPAC-IR): Chemistry, Manufacturing and Controls. In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation; FDA November 1995
- Food and Drug Administration. FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms; FDA August 1997
- Food and Drug Administration. FDA Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations; FDA September 1997
- Food and Drug Administration. FDA Guidance for Industry: Modified Release Oral Dosage Forms: Scale-up and Post-Approval Changes (SUPAC-MR): Chemistry, Manufacturing and Controls. In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation; FDA September 1997
- Sathe P. M., Tsong Y., Shah V. P. In-Vitro Dissolution Profile Comparison: Statistics and Analysis, Model Dependent Approach. Pharm. Res. 1996; 13(12)1799–1803
- Polli J. E., Rekhi G. S., Augsburger L. L., Shah V. P. Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate Tablets. J. Pharm. Sci. 1997; 86(6)690–700
- De Maesschalck R. Chemometric Characterisation of Pharmaceutical Substances and Products. Ph.D. thesis, Free University of Brussels, Belgium 2000
- Lindsey J. K. Parametric Statistical Inference. Clarendon Press, OxfordUK 1996